ADAG
Price
$2.93
Change
-$0.05 (-1.68%)
Updated
Sep 25 closing price
Capitalization
200.09M
67 days until earnings call
Intraday BUY SELL Signals
LENZ
Price
$3.92
Change
+$0.19 (+5.11%)
Updated
Sep 25 closing price
Capitalization
116.88M
46 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ADAG vs LENZ

ADAG vs LENZ Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ADAG vs. LENZ commentary
Sep 26, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADAG is a Hold and LENZ is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
Loading...
TECHNICAL ANALYSIS
Technical Analysis
ADAGLENZ
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 1 day ago
83%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 1 day ago
80%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 1 day ago
78%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 10 days ago
84%
Bullish Trend 5 days ago
85%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 3 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 1 day ago
80%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 1 day ago
88%
COMPARISON
Comparison
Sep 26, 2026
Stock price -- (ADAG: $2.93 vs. LENZ: $3.91)
Brand notoriety: ADAG and LENZ are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADAG: 92% vs. LENZ: 118%
Market capitalization -- ADAG: $200.09M vs. LENZ: $116.88M
ADAG [@Biotechnology] is valued at $200.09M. LENZ’s [@Biotechnology] market capitalization is $116.88M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $132.4B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADAG’s FA Score shows that 1 FA rating(s) are green while LENZ’s FA Score has 1 green FA rating(s).

  • ADAG’s FA Score: 1 green, 4 red.
  • LENZ’s FA Score: 1 green, 4 red.
According to our system of comparison, ADAG is a better buy in the long-term than LENZ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADAG’s TA Score shows that 4 TA indicator(s) are bullish while LENZ’s TA Score has 3 bullish TA indicator(s).

  • ADAG’s TA Score: 4 bullish, 6 bearish.
  • LENZ’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, ADAG is a better buy in the short-term than LENZ.

Price Growth

ADAG (@Biotechnology) experienced а -11.48% price change this week, while LENZ (@Biotechnology) price change was -3.81% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.17%. For the same industry, the average monthly price growth was -13.24%, and the average quarterly price growth was +5.35%.

Reported Earning Dates

ADAG is expected to report earnings on Dec 02, 2026.

LENZ is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Biotechnology (-4.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
ADAG
Daily Signal:
Gain/Loss:
LENZ
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CEGX12.420.15
+1.24%
Tradr 2X Long CEG Daily ETF (CEGX)
FBCG63.780.29
+0.46%
Fidelity Blue Chip Growth ETF (FBCG)
SEPI29.290.13
+0.45%
Shelton Equity Premium Income ETF
OCTT48.500.13
+0.27%
AllianzIM U.S. Equity Buffer10 Oct ETF (OCTT)
ROCQ56.850.03
+0.06%
JPMorgan Nasdaq Equity Premium Yield ETF (ROCQ)

ADAG and

Correlation & Price change

A.I.dvisor tells us that ADAG and CYTK have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ADAG and CYTK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADAG
1D Price
Change %
ADAG100%
-1.68%
CYTK - ADAG
28%
Poorly correlated
-1.52%
GERN - ADAG
27%
Poorly correlated
N/A
OCGN - ADAG
27%
Poorly correlated
+2.00%
QCLS - ADAG
26%
Poorly correlated
-14.92%
LENZ - ADAG
26%
Poorly correlated
+5.24%
More

LENZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, LENZ has been loosely correlated with KRYS. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if LENZ jumps, then KRYS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LENZ
1D Price
Change %
LENZ100%
+5.24%
KRYS - LENZ
39%
Loosely correlated
+0.25%
LKFT - LENZ
38%
Loosely correlated
-3.23%
BCYC - LENZ
37%
Loosely correlated
-1.21%
MLTX - LENZ
37%
Loosely correlated
-0.66%
CELC - LENZ
36%
Loosely correlated
+0.19%
More